These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31415584)

  • 21. Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay.
    He W; Mullarkey CE; Miller MS
    Methods; 2015 Nov; 90():95-100. PubMed ID: 25957674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of measles, mumps and rubella viruses by immuno-colorimetric assay and its application in focus reduction neutralization tests.
    Vaidya SR; Kumbhar NS; Bhide VS
    Microbiol Immunol; 2014 Dec; 58(12):666-74. PubMed ID: 25244651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.
    Ratnam S; Gadag V; West R; Burris J; Oates E; Stead F; Bouilianne N
    J Clin Microbiol; 1995 Apr; 33(4):811-5. PubMed ID: 7790442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-specific lymphocyte proliferation assay and virus neutralization test for measurement of measles-specific immunity in 15-19 years old high school students in Tehran, Iran.
    Jamehdar SA; Sabahi F; Zandi K; Shafiee A; Zadeh SF; Jalilian FA
    Pak J Biol Sci; 2007 Nov; 10(22):4144-7. PubMed ID: 19090296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
    Fiebelkorn AP; Coleman LA; Belongia EA; Freeman SK; York D; Bi D; Kulkarni A; Audet S; Mercader S; McGrew M; Hickman CJ; Bellini WJ; Shivakoti R; Griffin DE; Beeler J
    J Infect Dis; 2016 Apr; 213(7):1115-23. PubMed ID: 26597262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus Reduction Neutralization Test: A Single-Cell Imaging High-Throughput Virus Neutralization Assay for Dengue.
    Whiteman MC; Bogardus L; Giacone DG; Rubinstein LJ; Antonello JM; Sun D; Daijogo S; Gurney KB
    Am J Trop Med Hyg; 2018 Dec; 99(6):1430-1439. PubMed ID: 30350775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a robust and standardized immunoserological assay for detection of anti-measles IgG antibodies in human sera.
    Böröcz K; Csizmadia Z; Markovics Á; Mészáros V; Farkas K; Telek V; Varga V; Maloba GO; Bodó K; Najbauer J; Berki T; Németh P
    J Immunol Methods; 2019 Jan; 464():1-8. PubMed ID: 30056035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced Antibodies.
    Asati A; Kachurina O; Karol A; Dhir V; Nguyen M; Parkhill R; Kouiavskaia D; Chumakov K; Warren W; Kachurin A
    PLoS One; 2016; 11(2):e0144261. PubMed ID: 26863313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.
    Rabenau HF; Marianov B; Wicker S; Allwinn R
    Med Microbiol Immunol; 2007 Sep; 196(3):151-5. PubMed ID: 17308917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.
    Atabani SF; Obeid OE; Chargelegue D; Aaby P; Whittle H; Steward MW
    J Virol; 1997 Oct; 71(10):7240-5. PubMed ID: 9311797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance for epidemiological studies anti-measles antibody detection examined by enzyme immunoassay (EIA) and plaque reduction neutralization test (PRNT).
    Siennicka J; Częścik A; Trzcińska A
    Przegl Epidemiol; 2014; 68(3):417-20, 527-9. PubMed ID: 25394302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles immunity and response to revaccination among secondary school children in Cumbria.
    Calvert N; Cutts F; Irving R; Brown D; Marsh J; Miller E
    Epidemiol Infect; 1996 Feb; 116(1):65-70. PubMed ID: 8626005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
    Azami NA; Moi ML; Takasaki T
    Methods Mol Biol; 2016; 1426():273-82. PubMed ID: 27233280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired neutralizing activity by transplacental measles antibodies in infants born to HIV-1-infected mothers.
    Farouk S; Navér L; Smedman L
    Acta Paediatr; 2012 Nov; 101(11):e500-4. PubMed ID: 22816388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
    Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
    J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran.
    Fatemi Nasab GS; Salimi V; Abbasi S; Adjami Nezhad Fard F; Mokhtari Azad T
    Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27777263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
    Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
    J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a micro-neutralization assay for ebolaviruses using a replication-competent vesicular stomatitis hybrid virus and a quantitative PCR readout.
    Lee SS; Phy K; Peden K; Sheng-Fowler L
    Vaccine; 2017 Oct; 35(41):5481-5486. PubMed ID: 28427845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.
    Gagneur A; Pinquier D; Aubert M; Balu L; Brissaud O; De Pontual L; Gras Le Guen C; Hau-Rainsard I; Mory O; Picherot G; Stephan JL; Cohen B; Caulin E; Soubeyrand B; Reinert P
    Clin Vaccine Immunol; 2008 Dec; 15(12):1845-50. PubMed ID: 18815232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.